Your browser doesn't support javascript.
loading
Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors.
Eder, Matthias; Pavan, Silvia; Bauder-Wüst, Ulrike; van Rietschoten, Katerine; Baranski, Ann-Christin; Harrison, Helen; Campbell, Spencer; Stace, Catherine L; Walker, Edward H; Chen, Liuhong; Bennett, Gavin; Mudd, Gemma; Schierbaum, Ursula; Leotta, Karin; Haberkorn, Uwe; Kopka, Klaus; Teufel, Daniel P.
Affiliation
  • Eder M; Department of Nuclear Medicine, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Pavan S; Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), partner site Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Bauder-Wüst U; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • van Rietschoten K; Division of Radiopharmaceutical Chemistry, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Baranski AC; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Harrison H; Department of Nuclear Medicine, University Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Campbell S; Division of Radiopharmaceutical Development, German Cancer Consortium (DKTK), partner site Freiburg, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Stace CL; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Walker EH; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Chen L; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Bennett G; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Mudd G; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Schierbaum U; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Leotta K; Bicycle Therapeutics Limited, Babraham Research Campus, Cambridge, United Kingdom.
  • Haberkorn U; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kopka K; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Teufel DP; Clinical Cooperation Unit Nuclear Medicine, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Cancer Res ; 79(4): 841-852, 2019 02 15.
Article de En | MEDLINE | ID: mdl-30606721

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides cycliques / Régulation de l'expression des gènes codant pour des enzymes / Antienzymes / Matrix metalloproteinase 14 / Fibrosarcome / Anticorps monoclonaux Type d'étude: Prognostic_studies Limites: Animals / Humans / Male Langue: En Journal: Cancer Res Année: 2019 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Peptides cycliques / Régulation de l'expression des gènes codant pour des enzymes / Antienzymes / Matrix metalloproteinase 14 / Fibrosarcome / Anticorps monoclonaux Type d'étude: Prognostic_studies Limites: Animals / Humans / Male Langue: En Journal: Cancer Res Année: 2019 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: États-Unis d'Amérique